The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Research Report 2025
Synopsis
In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
The global Biologics Contract Development and Manufacturing Organization(CDMO) market was valued at US$ 11310 million in 2023 and is anticipated to reach US$ 23690 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Biologics Contract Development and Manufacturing Organization(CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics Contract Development and Manufacturing Organization(CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics Contract Development and Manufacturing Organization(CDMO) in Big Pharma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics Contract Development and Manufacturing Organization(CDMO) include Lonza, Hansen, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, Samsung BioLogics, AGC Biologics, Catalent and Wuxi Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Contract Development and Manufacturing Organization(CDMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Contract Development and Manufacturing Organization(CDMO).
Report Scope
The Biologics Contract Development and Manufacturing Organization(CDMO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Contract Development and Manufacturing Organization(CDMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Contract Development and Manufacturing Organization(CDMO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
Segment by Type
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Segment by Application
Big Pharma
Small Pharma
Generic Pharma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Development and Manufacturing Organization(CDMO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.
The global Biologics Contract Development and Manufacturing Organization(CDMO) market was valued at US$ 11310 million in 2023 and is anticipated to reach US$ 23690 million by 2030, witnessing a CAGR of 10.9% during the forecast period 2024-2030.
North American market for Biologics Contract Development and Manufacturing Organization(CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Biologics Contract Development and Manufacturing Organization(CDMO) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Biologics Contract Development and Manufacturing Organization(CDMO) in Big Pharma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Biologics Contract Development and Manufacturing Organization(CDMO) include Lonza, Hansen, Boehringer Ingelheim BioXcellence, Thermo Fisher Scientific, Samsung BioLogics, AGC Biologics, Catalent and Wuxi Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Biologics Contract Development and Manufacturing Organization(CDMO), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Contract Development and Manufacturing Organization(CDMO).
Report Scope
The Biologics Contract Development and Manufacturing Organization(CDMO) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Contract Development and Manufacturing Organization(CDMO) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Contract Development and Manufacturing Organization(CDMO) companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
Segment by Type
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Segment by Application
Big Pharma
Small Pharma
Generic Pharma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Contract Development and Manufacturing Organization(CDMO) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biologics Contract Development Services
1.2.3 Biologics Contract Manufacturing Services
1.3 Market by Application
1.3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Perspective (2019-2030)
2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Growth Trends by Region
2.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Region (2019-2024)
2.2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Region (2025-2030)
2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Dynamics
2.3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Industry Trends
2.3.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
2.3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
2.3.4 Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue
3.1.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue (2019-2024)
3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Players (2019-2024)
3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue
3.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio
3.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2023
3.5 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Area Served
3.6 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
3.7 Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Type
4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Type (2019-2024)
4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2025-2030)
5 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Application
5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Application (2019-2024)
5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2019-2030)
6.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024)
6.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2019-2030)
7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024)
7.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2019-2030)
8.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2019-2030)
9.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024)
9.4 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2019-2030)
10.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.1.4 Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Hansen
11.2.1 Hansen Company Detail
11.2.2 Hansen Business Overview
11.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.2.4 Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.2.5 Hansen Recent Development
11.3 Boehringer Ingelheim BioXcellence
11.3.1 Boehringer Ingelheim BioXcellence Company Detail
11.3.2 Boehringer Ingelheim BioXcellence Business Overview
11.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.3.4 Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.3.5 Boehringer Ingelheim BioXcellence Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung BioLogics
11.5.1 Samsung BioLogics Company Detail
11.5.2 Samsung BioLogics Business Overview
11.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.5.4 Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.5.5 Samsung BioLogics Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Detail
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.6.4 AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.6.5 AGC Biologics Recent Development
11.7 Catalent
11.7.1 Catalent Company Detail
11.7.2 Catalent Business Overview
11.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.7.4 Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.7.5 Catalent Recent Development
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Detail
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.8.4 Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2019-2024)
11.8.5 Wuxi Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
